查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566774

胃內球囊市場：按類型、填充材料、最終用戶分類：2024-2033 年全球機會分析和產業預測

Intragastric Balloons Market By Type (Single, Dual, Triple), By Filling Material (Gas Filled, Saline Filled) By End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球胃內球囊市場價值為3,220萬美元，預計2024年至2033年複合年成長率為13.6%，到2033年將達到1.153億美元。

胃內球囊是一種非手術醫療設備，旨在透過釋放胃部空間、使人感到飽足並減少進食量來幫助人們減肥。透過內視鏡手術將氣球放入胃中，並充滿生理食鹽水或氣體，佔據胃的一部分並降低攝取食物的能力。這種方法可以幫助您堅持低熱量飲食，養成更健康的飲食習慣，並支持減肥。這些球囊對於不適合或不希望避免胃繞道手術或袖狀切除術等外科手術的肥胖患者特別有利。

推動胃內球囊市場成長的是與久坐的生活方式、不健康的飲食和遺傳傾向等多種因素相關的肥胖盛行率的上升。隨著這些因素在世界各地變得越來越普遍，肥胖的發生率持續上升。因此，越來越多的人正在尋求有效的減重解決方案，以降低這些健康風險並改善其整體健康。對肥胖管理解決方案不斷成長的需求正在推動胃內球囊等干涉措施的市場發展，這種干預措施提供了一種微創的減重方法。例如，57.0%尋求微創治療的患者是在醫療專業人員的影響下做出決定的，因為他們被推薦進行微創治療，並且報告治療後較少感覺到缺點。

然而，報銷政策的缺乏阻礙了胃內球囊的推廣。在許多醫療保健系統中，胃內球囊治療的保險範圍預計不足或根本不存在，導致患者自付費用較高。這種經濟障礙阻礙了患者尋求治療，尤其是那些無法負擔費用或保險範圍不足的患者。另一方面，新產品的採用預示著市場成長的有利機會。例如，2022年9月，美國醫療設備製造商Allurion Technologies在印度推出了減重解決方案－可吞嚥式胃氣球。該產品聲稱在16週內體重平均減輕10-15%。

分部概覽

胃內球囊產業分為類型、填充材料、最終用戶和地區。依類型可分為單層、雙層和三層。根據填充材的不同，有充氣型和生理食鹽水型兩種。依最終用戶分類，可分為醫院、門診手術中心 (ASC) 等。從區域來看，分析涵蓋北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

按類型分類，2023 年胃內球囊市場中單一細分市場的收益最高。

從填充材料來看，2023年生理食鹽水填充細分市場佔據最高佔有率。

按最終用戶分類，醫院細分市場在 2023 年佔據最大市場佔有率。

按地區分類，北美在 2023 年佔據胃內球囊市場的主導地位。

競爭場景

該報告可以客製化。

  • 監管指引
  • 根據客戶興趣新增其他公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 擴大公司簡介列表
  • 歷史市場資料

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章胃內球囊市場：依類型

  • 市場概況
  • 單身的
  • 雙重的
  • 三倍

第5章胃內球囊市場：依填充材料分類

  • 市場概況
  • 氣體填充
  • 生理食鹽水食鹽水填充

第6章胃內球囊市場：依最終用戶分類

  • 市場概況
  • 醫院
  • 門診手術中心
  • 其他

第7章胃內球囊市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國胃內球囊市場
    • 加拿大胃內球囊市場
    • 墨西哥胃內球囊市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國胃內球囊市場
    • 德國胃內球囊市場
    • 義大利胃內球囊市場
    • 西班牙胃內球囊市場
    • 英國胃內球囊市場
    • 其他歐洲胃內球囊市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國胃內球囊市場
    • 日本胃內球囊市場
    • 印度胃內球囊市場
    • 韓國胃內球囊市場
    • 澳洲胃內球囊市場
    • 其他亞太地區胃內球囊市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西胃內球囊市場
    • 南非胃內球囊市場
    • 沙烏地阿拉伯胃內球囊市場
    • 其他拉丁美洲/中東/非洲胃內球囊市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Obalon Therapeutics
  • Apollo Endosurgery Inc.
  • Allurion Technologies Inc.
  • Spatz Medical
  • ReShape Lifesciences
  • Lexel Medical
  • Endalis
  • MEDSIL
  • Silimed Industria De Implantes Ltda.
簡介目錄
Product Code: A03775

The global intragastric balloons market was valued at $32.2 million in 2023, and is projected to reach $115.3 million by 2033, growing at a CAGR of 13.6% from 2024 to 2033.

Intragastric balloons are medical devices that do not require surgery and are created to aid in weight loss by taking up space in the stomach, leading to a sensation of fullness and decreased food consumption. These balloons are placed in the stomach through an endoscopic procedure and are filled with saline or gas to occupy a part of the stomach, reducing its capacity for food intake. This method helps people stick to low-calorie diets and develop healthier eating habits, which in turn supports weight loss. These balloons are especially advantageous for individuals dealing with obesity who may not be eligible for or prefer to avoid surgical procedures such as gastric bypass or sleeve gastrectomy.

The growth of the intragastric balloons market is driven by rise in the obesity rates related to various factors such as sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. As these factors become more prevalent globally, the incidence of obesity continues to rise. Consequently, individuals are increasingly seeking effective weight loss solutions to mitigate these health risks and improve their overall well-being. This growing demand for obesity management solutions drives the market for interventions such as intragastric balloons, which offer a minimally invasive approach to weight loss. For instance, 57.0% of the patients who preferred minimally invasive treatment made their decision under the influence of the healthcare professionals as they recommended minimally invasive treatment and reported less perceived disadvantages following their treatment.

However, lack of reimbursement policies hinders the adoption of intragastric balloons. In many healthcare systems, the coverage for intragastric balloon procedures is expected to be insufficient or non-existent, resulting in high out-of-pocket costs for patients. This financial barrier deters individuals from seeking treatment, particularly those with limited financial resources or inadequate insurance coverage. On the other hand, introduction of new products offers lucrative opportunities for the growth of the market. For instance, in September 2022, Allurion Technologies, the U.S.-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India. The product claims to reduce weight by 10-15% on average within 16 weeks.

Segmentation Overview

The intragastric balloons industry is segmented into type, filling material, end user, and region. By type, the market is classified into single, dual, and triple. Depending on the filling material, it is bifurcated into gas filled and saline filled. According to end user, the market is categorized into hospitals, ambulatory surgical centers (ASC), and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the single segment generated the largest revenue in the intragastric balloons market in 2023.

Depending on the filling material, the saline filled segment held the highest share in the market in 2023.

According to end users, the hospitals segment accounted for the largest market share in 2023.

Region wise, North America dominated the intragastric balloons market in 2023.

Competitive Scenario

The major players operating in the intragastric balloons market include Obalon Therapeutics, Apollo Endosurgery Inc., Allurion Technologies Inc., Spatz Medical, ReShape Lifesciences, Lexel Medical, Endalis, MEDSIL, and Silimed. Other players in the intragastric balloons market include Districlass Medical, and Helioscopie. These players have adopted several strategies, including mergers & acquisitions, partnerships, collaborations, and product innovation & diversification to maintain their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type

  • Single
  • Dual
  • Triple

By Filling Material

  • Gas Filled
  • Saline Filled

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Obalon Therapeutics
    • Apollo Endosurgery Inc.
    • Allurion Technologies Inc.
    • Spatz Medical
    • ReShape Lifesciences
    • Lexel Medical
    • Endalis
    • MEDSIL
    • Silimed Industria de Implantes Ltda.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: INTRAGASTRIC BALLOONS MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Single
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Dual
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Triple
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: INTRAGASTRIC BALLOONS MARKET, BY FILLING MATERIAL

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Filling Material
  • 5.2. Gas Filled
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Saline Filled
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: INTRAGASTRIC BALLOONS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: INTRAGASTRIC BALLOONS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Filling Material
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Intragastric Balloons Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Filling Material
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Intragastric Balloons Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Filling Material
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Intragastric Balloons Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Filling Material
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Filling Material
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Intragastric Balloons Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Filling Material
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Intragastric Balloons Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Filling Material
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Intragastric Balloons Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Filling Material
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Intragastric Balloons Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Filling Material
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Intragastric Balloons Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Filling Material
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Intragastric Balloons Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Filling Material
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Filling Material
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Intragastric Balloons Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Filling Material
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Intragastric Balloons Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Filling Material
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Intragastric Balloons Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Filling Material
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Intragastric Balloons Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Filling Material
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Intragastric Balloons Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Filling Material
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Intragastric Balloons Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Filling Material
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Filling Material
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Intragastric Balloons Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Filling Material
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Intragastric Balloons Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Filling Material
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Intragastric Balloons Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Filling Material
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Intragastric Balloons Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Filling Material
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Obalon Therapeutics
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Apollo Endosurgery Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Allurion Technologies Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Spatz Medical
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. ReShape Lifesciences
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Lexel Medical
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Endalis
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. MEDSIL
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Silimed Industria De Implantes Ltda.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments